In Q1 2025, vertical software financing reached $10.4 billion across 552 deals in the US and Canada, with healthcare AI leading the sector in investment activity.
Target Information
The quarter ending Q1 2025 saw significant financing activity in the vertical software sector, with $10.4 billion raised across 552 deals in the United States and Canada. This amount represented 42% of the total capital raised in this space, reflecting strong investor interest, particularly in early-stage companies. The majority of capital was concentrated in the healthcare and AI sectors, with notable rounds around $250 million for Abridge and $30 million for Freed, exemplifying the substantial growth potential of these verticals.
One key player, Abridge, specializes in automating clinical documentation through AI, along with extensive partnership strategies with healthcare systems. With this new funding, Abridge aims to enhance its proprietary technology aimed at improving healthcare communication. Similarly, Freed’s rise in the market showcases the dual paths to success in healthcare AI, with their affordable offerings catering to thousands of clinicians.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
Throughout 2025, the vertical software industry, particularly in the US and Canada, has demonstrated resilience and adaptability amid evolving market conditions. The vertical AI segment is witnessing increased venture capital participation, with h
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
LPOXY Therapeutics, Inc. → Xeno Biosciences Inc.
2025
CitiusTech Inc. → Health Data Movers Inc.
2025
Eli Lilly and Company → SiteOne Therapeutics, Inc.
2025
CCC Intelligent Solutions
invested in
EvolutionIQ
in 2025
in a Other deal
Disclosed details
Transaction Size: $730M
Enterprise Value: $595M
Equity Value: $730M